This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 May;31(5):350-2.

doi: 10.1111/j.2042-7158.1979.tb13520.x.

Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation

L A Wakile, T P Sloan, J R Idle, R L Smith

PMID: 37314
DOI: 10.1111/j.2042-7158.1979.tb13520.x

Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation

L A Wakile et al. J Pharm Pharmacol. 1979 May.

. 1979 May;31(5):350-2.

doi: 10.1111/j.2042-7158.1979.tb13520.x.

Authors

L A Wakile, T P Sloan, J R Idle, R L Smith

PMID: 37314
DOI: 10.1111/j.2042-7158.1979.tb13520.x

No abstract available

PubMed Disclaimer

Similar articles

Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
Idle JR, Smith RL. Idle JR, et al. Drug Metab Rev. 1979;9(2):301-17. doi: 10.3109/03602537908993896. Drug Metab Rev. 1979. PMID: 158499 Review. No abstract available.
Genetically determined defcts of oxidation at carbon centres of drugs.
Smith RL, Idle JR, Mahgoub AA, Sloan TP, Lancaster R. Smith RL, et al. Lancet. 1978 Apr 29;1(8070):943-4. doi: 10.1016/s0140-6736(78)90724-9. Lancet. 1978. PMID: 76883 No abstract available.
Genetically determined polymorphisms in drug oxidation.
Jacqz E, Hall SD, Branch RA. Jacqz E, et al. Hepatology. 1986 Sep-Oct;6(5):1020-32. doi: 10.1002/hep.1840060534. Hepatology. 1986. PMID: 3758933 No abstract available.
[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
Eichelbaum M. Eichelbaum M. Internist (Berl). 1983 Mar;24(3):117-27. Internist (Berl). 1983. PMID: 6135670 Review. German. No abstract available.
Pharmacogenetic polymorphism of drug metabolism.
Paxton JW. Paxton JW. N Z Med J. 1984 Aug 22;97(762):567-9. N Z Med J. 1984. PMID: 6591031 No abstract available.

See all similar articles

Cited by

Assessment of the drug metabolism capacity of the liver.
Park BK. Park BK. Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x. Br J Clin Pharmacol. 1982. PMID: 6128018 Free PMC article. Review. No abstract available.
Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver.
Kahn GC, Boobis AR, Murray S, Brodie MJ, Davies DS. Kahn GC, et al. Br J Clin Pharmacol. 1982 May;13(5):637-45. doi: 10.1111/j.1365-2125.1982.tb01430.x. Br J Clin Pharmacol. 1982. PMID: 7082530 Free PMC article.
Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
Eichelbaum M. Eichelbaum M. Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22. doi: 10.2165/00003088-198207010-00001. Clin Pharmacokinet. 1982. PMID: 7042170 Review. No abstract available.
Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.
Oram M, Wilson K, Burnett D, Al-Dabbagh SG, Idle JR, Smith RL. Oram M, et al. Eur J Clin Pharmacol. 1982;23(2):147-50. doi: 10.1007/BF00545969. Eur J Clin Pharmacol. 1982. PMID: 7140803

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
- Wiley